EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

Cell Death & Differentiation, Published online: 23 October 2019; doi:10.1038/s41418-019-0435-1EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

Source: Cell Death and Differentiation - October 22, 2019 Category: Cytology Authors: L. Fitzsimmons R. Cartlidge C. Chang N. Sejic L. C. A. Galbraith C. D. Suraweera D. Croom-Carter G. Dewson R. J. Tierney A. I. Bell C. Shannon-Lowe M. J. Herold A. B. Rickinson P. M. Colman D. C. S. Huang A. Strasser M. Kvansakul M. Rowe G. L. Kelly Source Type: research